KCTD10 and neoplasm: In follow-up studies, we will employ single-cell RNA sequencing and flow cytometry to comprehensively profile immune cell composition and activation states, further enabling a deep understanding of how KCTD10 shapes the tumor immune microenvironment and influences immune responses in subtype-specific contexts.